Physician profile
Zackquill J Morgan
NPI 1922534601
$730.41
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $15.26 · 2021: $301 · 2022: $94.34 · 2023: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $496.08 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $75.93 | 2023 | Zerbaxa, Dificid, Recarbrio |
| Tetraphase Pharmaceuticals, INC. | $30.82 | 2019 | |
| Csl Behring | $30.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.24 | 2019-2022 | |
| Pfizer INC. | $28.84 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.85 | 2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $19.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zackquill Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.